Hydrocortisone sodium succinate reversibly inhibits human neutrophil oxidative activity at clinically relevant concentrations.
D000328:Adult; D001592:Benzyl Alcohols; D004926:Escherichia coli / Q000648:ultrastructure*; D006801:Humans; D006854:Hydrocortisone / Q000031:analogs & derivatives* / Q000494:pharmacology; D066298:In Vitro Techniques; D008163:Luminescent Measurements; D009504:Neutrophils / Q000187:drug effects / Q000378:metabolism*; D010084:Oxidation-Reduction / Q000187:drug effects
D001592:Benzyl Alcohols; C007133:hydrocortisone hemisuccinate; D006854:Hydrocortisone